Oncolytics Biotech (ONCY) Earnings Date, Estimates & Call Transcripts $1.36 -0.02 (-1.45%) Closing price 04:00 PM EasternExtended Trading$1.37 +0.01 (+0.74%) As of 05:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Oncolytics Biotech Earnings Summary Oncolytics Biotech issued Q2 2025 earnings on August 8, 2025, reporting an EPS of -$0.05, which beat analysts' consensus estimates of -$0.11 by $0.06. With a trailing EPS of -$0.27, Oncolytics Biotech's earnings are expected to decrease next year, from ($0.28) to ($0.30) per share. Upcoming Q3 Earnings DateNov. 11After Market ClosesEstimatedConsensus EPS (Aug. 8) -$0.11 Actual EPS (Aug. 8) -$0.05 Beat By $0.06 Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Press Release (8-K)ONCY Upcoming EarningsOncolytics Biotech's next earnings date is estimated for Tuesday, November 11, 2025, based on past reporting schedules. Powered by Get Oncolytics Biotech Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Oncolytics Biotech and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataONCY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Oncolytics Biotech Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.09-$0.08-$0.09Q2 20251-$0.11-$0.11-$0.11Q4 20251-$0.06-$0.06-$0.06 Oncolytics Biotech Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/11/2025(Estimated)--------8/8/2025Q2 2025-$0.11-$0.05+$0.06-$0.05--5/14/2025Q1 2025-$0.09-$0.06+$0.03-$0.06--8/1/2024Q2 2024-$0.08-$0.07+$0.01-$0.07--5/9/2024Q1 2024-$0.09-$0.07+$0.02-$0.07--3/7/2024Q4 2023-$0.11-$0.04+$0.07-$0.04--11/3/2023Q3 2023-$0.07-$0.10 -$0.03-$0.10-- Oncolytics Biotech Earnings - Frequently Asked Questions When is Oncolytics Biotech's earnings date? Oncolytics Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 11th, 2025 based off last year's report dates. Learn more on ONCY's earnings history. Did Oncolytics Biotech beat their earnings estimates last quarter? In the previous quarter, Oncolytics Biotech (NASDAQ:ONCY) reported ($0.05) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.11) by $0.06. Learn more on analysts' earnings estimate vs. ONCY's actual earnings. How much profit does Oncolytics Biotech generate each year? Oncolytics Biotech (NASDAQ:ONCY) has a recorded net income of -$23.14 million. ONCY has generated -$0.27 earnings per share over the last four quarters. What is Oncolytics Biotech's EPS forecast for next year? Oncolytics Biotech's earnings are expected to decrease from ($0.28) per share to ($0.30) per share in the next year. More Earnings Resources from MarketBeat Related Companies Compass Therapeutics Earnings Results Bicycle Therapeutics Earnings Results Prothena Earnings Results REGENXBIO Earnings Results Solid Biosciences Earnings Results CytomX Therapeutics Earnings Results Fulcrum Therapeutics Earnings Results Inhibrx Biosciences Earnings Results Monopar Therapeutics Earnings Results Monte Rosa Therapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff ConcernsCelsius Stock Surges After Blowout Earnings and Pepsi DealWhy DocuSign Could Be a SaaS Value Play After Q2 Earnings This page (NASDAQ:ONCY) was last updated on 10/6/2025 by MarketBeat.com Staff From Our Partners1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncolytics Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncolytics Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
